While there are a greater number of private psychedelics companies and organisations, the fifty-or-so public ones offer us a look ‘under the hood’, so to speak, given their requirement for quarterly filings. As such, let’s take a look at the health of publicly-traded psychedelics companies… Part of our Year in Review series By the end of 2022, there were around 50 psychedelics companies.


Previous articlePsychedelics Weekly – Client Data Concerns in Oregon, Hopeful Legalization in New Hampshire, and Vital & The Five Elements
Next articleExpanding ketamine’s horizons for rare neurological disorders